DOI:
10.1055/s-00000145
Dialyse aktuell
LinksClose Window
References
Guba M, Pratschke J, Hugo C et al.; SMART-Study Group.
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36 months after transplantation.
Transpl Int 2012;
25: 416-423
Access:
We do not assume any responsibility for the contents of the web pages of other providers.